Supplementary Material 1: 14 herbs of LSNYP.
Supplementary Material 1: 14 herbs of LSNYP.
Supplementary Material 2: 114 Potential active components.
Supplementary Material 2: 114 Potential active components.
Supplementary Material 3: 217 potential therapeutic targets.
Supplementary Material 3: 217 potential therapeutic targets.
Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.
Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.
BACKGROUND: Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecular mech…
Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…
Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…
ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis (EMS) is a common gynecological disease that causes dysmenorrhea, chronic pelvic pain and infertility. Luoshi Neiyi Prescription (LSNYP), a traditional Chinese medicine (TCM) formula, is used to…